US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veraxa Biotech Holding AG

1.26

+0.170015.60%

Post-market: 1.19-0.0700-5.56%19:40 EDT

Volume:1.86M

Turnover:2.36M

Market Cap:178.17M

PE:5.88

High:1.41

Open:1.08

Low:1.07

Close:1.09

52wk High:27.36

52wk Low:1.04

Shares:141.41M

Float Shares:36.77M

Volume Ratio:5.60

T/O Rate:5.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2142

EPS(LYR):-5.8037

ROE:-871.42%

ROA:-49.99%

PB:-9.38

PE(LYR):-0.22

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Veraxa Biotech Expands FDA-Aligned Non-Animal Testing Models, Aiming to Cut Animal Use in Oncology R&D

Veraxa Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/VRXA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRXA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","market":"US","secType":"STK","nameCN":"Veraxa Biotech Holding AG","latestPrice":1.26,"timestamp":1791576000000,"preClose":1.09,"halted":0,"volume":1862521,"hourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.26,"latestTime":"19:40 EDT","volume":9155,"amount":11072.8793,"timestamp":1791589234703,"change":-0.07,"changeRate":-0.055556,"amplitude":0.063492},"delay":0,"changeRate":0.1559633027522935,"floatShares":36767500,"shares":141407813,"eps":0.2142,"marketStatus":"Market Closed","change":0.17,"latestTime":"10-09 16:00:00 EDT","open":1.08,"high":1.4089,"low":1.07,"amount":2357306.2224735,"amplitude":0.310917,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.2142,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.09,"preHourTrading":{"tag":"盘前","latestPrice":1.0999,"preClose":1.09,"latestTime":"09:26 EDT","volume":82,"amount":90.46659840000001,"timestamp":1791552415129,"change":0.0099,"changeRate":0.009083,"amplitude":0.028073},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.26,"latestTime":"19:40 EDT","volume":9155,"amount":11072.8793,"timestamp":1791589234703,"change":-0.07,"changeRate":-0.055556,"amplitude":0.063492},"volumeRatio":5.5972675448200615},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRXA\",,,,,undefined,":{"symbol":"VRXA","floatShares":36767500,"roa":"-49.99%","roe":"-871.42%","lyrEps":-5.803658,"volumeRatio":5.5972675448200615,"shares":141407813,"dividePrice":0,"high":1.4089,"amplitude":0.310917,"preClose":1.09,"low":1.07,"week52Low":1.04,"pbRate":"-9.38","psRate":"6310.27","week52High":27.36,"institutionHeld":0,"latestPrice":1.26,"eps":0.2142,"divideRate":0,"volume":1862521,"delay":0,"ttmEps":0.2142,"open":1.08,"prevYearClose":18.65,"prevWeekClose":1.13,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":1.13,"twentyDayClose":1.65,"sixtyDayClose":2.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRXA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRXA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRXA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRXA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRXA","date":"2026-10-09","current":5.882353,"percent":0.685714,"low":-3.022108,"twenty":-2.642356,"median":-2.342735,"eighty":-1.331869,"high":-0.413162,"avg":-2.052749,"sd":0.727564,"marketCap":154134516},"quantilePoints":[{"date":"2026-08-21","current":-1.35335,"twenty":-1.349054,"median":-1.34261,"eighty":-1.336165,"marketCap":47660725},{"date":"2026-08-28","current":-1.03732,"twenty":-1.349054,"median":-1.281094,"eighty":-1.194963,"marketCap":36312933},{"date":"2026-09-04","current":-2.622384,"twenty":-1.391748,"median":-1.265172,"eighty":-0.552029,"marketCap":216353953},{"date":"2026-09-11","current":-2.842124,"twenty":-2.738773,"median":-1.34261,"eighty":-1.03732,"marketCap":233322891},{"date":"2026-09-18","current":-2.57236,"twenty":-2.751957,"median":-2.365287,"eighty":-1.181392,"marketCap":207869485},{"date":"2026-09-25","current":-2.481882,"twenty":-2.738773,"median":-2.472656,"eighty":-1.249249,"marketCap":199385016},{"date":"2026-10-02","current":-2.09825,"twenty":-2.642883,"median":-2.446678,"eighty":-1.281094,"marketCap":168275297},{"date":"2026-10-09","current":-1.927596,"twenty":-2.642356,"median":-2.342735,"eighty":-1.331869,"marketCap":154134516}],"updateTime":1791733304658},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRXA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673014180","title":"VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673014180?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:00","pubTimestamp":1791392422,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, October 7th, 2026, FinanceWire VERAXA Biotech (NASDAQ:VRXA), a developer of next-generation antibody-based cancer the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-fda-aligned-methods-to-reduce-animal-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/veraxa-biotech-nasdaq-vrxa-advances-fda-aligned-methods-to-reduce-animal-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QID","BK4585","FTEC","XBI","PSQ","QQQM","QYLG",".IXIC","SQQQ","NDX","QQQY","TQQY","NQmain","NVIW.SI","QQQE","BK4581","LABU","QQQ","IYW","TQQQ","QDTE","BK4139","TECS","QQQJ","03086","ONEQ","VRXA","QLD","BK4588","JEPQ","MNQmain","QQQA","GPIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013460","title":"Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013460?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:09","pubTimestamp":1791378540,"startTime":"0","endTime":"0","summary":"Since going public, Veraxa Biotech has endured a deep slump that has pushed its stock into single-digit territory. Its recovery may hinge on the adoption of new drug-testing protocols to accelerate it","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LU1162221912.USD","LU2089284900.SGD","AGNG","IE00B3PB1722.GBP","IE00BLSP4452.SGD","LU0965509101.SGD","BK4534","LU0708994859.HKD","LU1839511570.USD","LU1923622614.USD","AZNH","LU1934455194.USD","LU0114720955.EUR","LU0122379950.USD","LU0456855351.SGD","PPH","XBI","GLAM","LU0198837287.USD","LU0942090050.USD","XLV","BK4581","LU1720051017.SGD","LU2125909247.SGD","LU2237443465.HKD","VHT","BK4566","LU2456880835.USD","FTXH","VRXA","TRUH","LU0912757837.SGD","LU1829250122.USD","IYH","LU1057294990.SGD","MEDX","ABBV","FHLC","IXJ","PJP","LU2133065610.SGD","IE00BN8TJ469.HKD","LU1720051108.HKD","LU1929549753.HKD","RXL","IE00B19Z3581.USD","JDOC","LU0949170772.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673109209","title":"Veraxa Biotech Expands FDA-Aligned Non-Animal Testing Models, Aiming to Cut Animal Use in Oncology R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673109209?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370854,"startTime":"0","endTime":"0","summary":"Veraxa Biotech expands FDA-aligned non-animal testing models, aiming to cut animal use in oncology R&DVeraxa outlined an ESG-linked shift to FDA-aligned New Approach Methodologies to cut animal testin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL8MQ7sC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","BK4139","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","VRXA","BK4585","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673409206","title":"Veraxa Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2673409206","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673409206?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUAB2KMJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRXA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":20,"pageCount":1,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VRXA\",params:#limit:6,delay:false,,,undefined,":[]}}